PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA

This adverse event was reported 81 times

These drugs are most commonly taken by patients reporting PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA:

# Drug Count
0 ADALIMUMAB 9
1 ETANERCEPT 7
2 METHOTREXATE 6
3 METHOTREXATE SODIUM 6
4 AMLODIPINE 5
5 FAMOTIDINE 5
6 CYCLOSPORINE 4
7 HYDROXYCHLOROQUINE 4
8 INFLIXIMAB 4
9 METHYLPREDNISOLONE 4
See all common drugs associated with PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA

PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RIFAPENTINE 1 0.0019
1 TAURINE 1 0.0013
2 TRIMIPRAMINE 1 0.0009
3 DHEA (DEHYDROEPIANDROSTERONE) 1 0.0005
4 TRIAZOLAM 1 0.0002
5 SELENIUM 1 0.0002
6 TREMELIMUMAB 1 0.0002
7 ZANUBRUTINIB 1 0.0002
8 DASPONE 2 0.0002
9 DAPSONE GEL, 5% 2 0.0002
See all drugs enriched for association with PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA

PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Rifamycin Antimycobacterial [EPC] 1 0.0003
1 Sulfone [EPC] 2 0.0002
2 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 3 0.0001
3 Provitamin D2 Compound [EPC] 3 0.0001
4 CD30-directed Immunoconjugate [EPC] 1 0.0001
5 Human Immunoglobulin G [EPC] 1 0.0000
6 Bile Acid [EPC] 1 0.0000
7 Progesterone [EPC] 1 0.0000
8 Antimycobacterial [EPC] 1 0.0000
9 Histamine-2 Receptor Antagonist [EPC] 5 0.0000
See all drug classes enriched for association with PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA